Shah Rukh, Ajay, Tiger Face FDA Probe

Shah Rukh Khan, Ajay Devgn, and Tiger Shroff are under scrutiny by the Food and Drug Administration (FDA) for their involvement in a Vimal advertisement. The FDA is investigating the claims made in the ad, which allegedly violates the FDA's guidelines.

The advertisement in question features the three Bollywood stars endorsing Vimal, a popular pan masala brand. However, the FDA has taken issue with the claims made in the ad, which they believe are misleading and unsubstantiated.

According to sources, the FDA has sent notices to the three actors, as well as the manufacturer of Vimal, asking them to provide evidence to support the claims made in the advertisement. The FDA is also investigating whether the ad complies with the Food Safety and Standards Authority of India (FSSAI) regulations.

Shah Rukh Khan, Ajay Devgn, and Tiger Shroff are yet to respond to the FDA's notice. The three actors are popular endorsers of various brands, and their involvement in the Vimal advertisement has sparked controversy.

The FDA's move to investigate the Vimal advertisement is part of a larger crackdown on misleading advertisements in the country. The regulatory body has been actively monitoring advertisements to ensure that they comply with the guidelines and regulations set by the FSSAI.

The Vimal advertisement controversy has raised questions about the responsibility of celebrities in endorsing products. While celebrities have the right to endorse products, they also have a responsibility to ensure that the products they endorse comply with the law and do not mislead consumers.

The FDA's investigation into the Vimal advertisement is ongoing, and it remains to be seen what action will be taken against the three actors and the manufacturer of Vimal. The controversy has sparked a debate about the need for stricter regulations on advertisements and the role of celebrities in endorsing products.

In recent years, there have been several instances of celebrities being criticized for endorsing products that have been found to be misleading or unsubstantiated. The Vimal advertisement controversy is just the latest example of the need for greater scrutiny of advertisements and the role of celebrities in endorsing products.

The FDA's move to investigate the Vimal advertisement is a step in the right direction, as it highlights the need for greater transparency and accountability in advertising. As the investigation continues, it will be interesting to see what action is taken against the three actors and the manufacturer of Vimal.

The controversy surrounding the Vimal advertisement has significant implications for the advertising industry and the role of celebrities in endorsing products. It highlights the need for greater scrutiny of advertisements and the importance of ensuring that products comply with the law and do not mislead consumers.

In conclusion, the FDA's investigation into the Vimal advertisement is a significant development that highlights the need for greater transparency and accountability in advertising. The controversy surrounding the advertisement has sparked a debate about the responsibility of celebrities in endorsing products and the need for stricter regulations on advertisements.